Venture Capital

Updated:

ZhongMei Capital

ZhongMei Capital is a venture capital firm headquartered in San Francisco, United States. The firm invests in pre-clinical biopharmaceutical companies that...

ZhongMei Capital

ZhongMei Capital is a venture capital firm headquartered in San Francisco, United States. The firm invests in pre-clinical biopharmaceutical companies that have US-China collaboration opportunities. ZhongMei Capital focuses on undervalued assets for cross-border development.

General information

Firm type

Venture Capital

Location

Country

United States

City

San Francisco

Corporate office

San Francisco, United States

Sector focus

Venture CapitalUnited States

Frequently asked questions

What type of investments does ZhongMei Capital make?

ZhongMei Capital invests in pre-clinical biopharmaceutical companies with US-China collaboration opportunities.

Where is ZhongMei Capital headquartered?

ZhongMei Capital is headquartered in San Francisco, United States.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More San Francisco Venture Capital profiles